# Effect of Controlled Hypotension on Cerebral Oxygen Saturation

> **NCT02967029** · PHASE4 · COMPLETED · sponsor: **Istanbul University** · enrollment: 150 (actual)

## Conditions studied

- Hypotension Drug-Induced
- Cerebral Oxygen Saturation

## Interventions

- **DRUG:** Esmolol Hydrochloride
- **DRUG:** Remifentanil Hydrochloride

## Key facts

- **NCT ID:** NCT02967029
- **Lead sponsor:** Istanbul University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-01
- **Primary completion:** 2017-07-01
- **Final completion:** 2017-08-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02967029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02967029, "Effect of Controlled Hypotension on Cerebral Oxygen Saturation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02967029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*